Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Challenging Case Teaches Oncology Fellow the Power of Hope

October 30th 2017

Advanced esophageal cancer is a highly lethal malignancy and often spreads despite aggressive therapy.

Novartis to Add Lutathera to Portfolio in Planned $3.9-Billion Deal

October 30th 2017

Novartis has announced a planned $3.9-billion acquisition of Advanced Accelerator Applications, a radiopharmaceutical company that develops, produces, and commercializes Molecular Nuclear Medicines.

Treatment Modalities Evolving in Pancreatic Cancer

October 26th 2017

Mark J. Truty, MD, discusses sequencing treatments and advances in imaging technology in pancreatic cancer.

Cabozantinib Improves Survival in Phase III HCC Trial

October 17th 2017

Cabozantinib (Cabometyx) improved overall survival versus placebo in patients with advanced hepatocellular carcinoma who have previously received sorafenib (Nexavar), meeting the primary endpoint of the phase III CELESTIAL trial.

Dr. Ross on Biomarker Research Development in Liver Metastasis

October 11th 2017

Merrick I. Ross, MD, professor, Department of Surgical Oncology, Division of Surgery, The University of Texas MD Anderson Cancer Center, discusses biomarker research development for patients with liver metastasis.

Dr. Schmoll on the Toxicity of the CHARTA Study in CRC

October 10th 2017

Hans-Joachim Schmoll, MD, head, Department of Oncology and Hematology, associate professor, Internal Medicine, Hematology/Oncology, University Hospital Halle, discusses the toxicity of the CHARTA study for patients with colorectal cancer (CRC).

PEGPH20: Future Directions in Pancreatic Adenocarcinoma

October 10th 2017

PEGPH20: A Novel Agent for Pancreatic Adenocarcinoma

October 10th 2017

Pancreas Cancer Treatment Forecast

October 10th 2017

Pancreas Cancer: Investigational Targeted Approaches

October 10th 2017

Clinical Research in the Treatment of Pancreas Cancer

October 10th 2017

Management of Borderline Resectable Pancreas Cancer

October 10th 2017

Neoadjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

Role of Adjuvant Radiation Therapy in Pancreas Cancer

October 10th 2017

Adjuvant Therapy Recommendations in Pancreas Cancer

October 10th 2017

Pancreas Cancer: Incorporating Nanoliposomal Irinotecan

October 10th 2017

Palliative Care Recommendations in Pancreas Cancer

October 10th 2017

Modifying Chemotherapy Regimens in Pancreas Cancer

October 10th 2017

Sequential Therapy for Metastatic Pancreas Cancer

October 10th 2017

Precision Medicine for Pancreatic Cancer

October 10th 2017